Variant report
Variant | esv12414 |
---|---|
Chromosome Location | chr2:76314741-76315667 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:76309108..76311658-chr2:76313457..76316023,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs390810 | chr2:76314752-76314753 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs567210571 | chr2:76314770-76314771 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs534179608 | chr2:76314804-76314805 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs555503174 | chr2:76314881-76314882 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs538429577 | chr2:76314930-76314931 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs544343095 | chr2:76314961-76314962 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs556625396 | chr2:76315017-76315018 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs540767494 | chr2:76315053-76315054 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs140661470 | chr2:76315063-76315064 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs72822720 | chr2:76315112-76315113 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs560002048 | chr2:76315117-76315118 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs410954 | chr2:76315138-76315139 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs542930419 | chr2:76315157-76315158 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs150091809 | chr2:76315169-76315170 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs531346851 | chr2:76315194-76315195 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs395903 | chr2:76315201-76315202 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs571413822 | chr2:76315221-76315222 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs533556360 | chr2:76315237-76315238 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs552035966 | chr2:76315254-76315255 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs567146223 | chr2:76315262-76315263 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs535739788 | chr2:76315295-76315296 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs58742247 | chr2:76315320-76315321 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs534195986 | chr2:76315325-76315326 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs200453942 | chr2:76315331-76315332 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs394278 | chr2:76315359-76315360 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs528938800 | chr2:76315384-76315385 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs533376012 | chr2:76315385-76315386 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs138629061 | chr2:76315397-76315398 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs416264 | chr2:76315398-76315399 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs380810 | chr2:76315409-76315410 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs183075922 | chr2:76315417-76315418 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs79027358 | chr2:76315421-76315422 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs576819544 | chr2:76315445-76315446 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs78397731 | chr2:76315466-76315467 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs561239359 | chr2:76315482-76315483 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs12612816 | chr2:76315508-76315509 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs115364935 | chr2:76315549-76315550 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs187794289 | chr2:76315553-76315554 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs547535027 | chr2:76315554-76315555 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs386647483 | chr2:76315601-76315602 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs12615814 | chr2:76315602-76315603 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs560503849 | chr2:76315624-76315625 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs416093 | chr2:76315652-76315653 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Lung cancer | 18438408 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Mental retardation | 17124404 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Cancer | 17440070 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Breast cancer | 16272173 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:76312600-76315000 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr2:76315000-76316000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |